Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.655 EUR | +3.04% | -2.15% | -59.33% |
May. 30 | Evotec Partners With French Institutions, Company to Research Obesity | MT |
May. 30 | Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases | MT |
Sales 2024 * | 881M 956M | Sales 2025 * | 1.04B 1.12B | Capitalization | 1.53B 1.66B |
---|---|---|---|---|---|
Net income 2024 * | -27M -29.28M | Net income 2025 * | 32M 34.7M | EV / Sales 2024 * | 2.05 x |
Net Debt 2024 * | 269M 292M | Net Debt 2025 * | 235M 255M | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
-58.3
x | P/E ratio 2025 * |
32.3
x | Employees | 5,055 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | +3.04% | ||
1 week | -5.77% | ||
Current month | -11.14% | ||
1 month | -11.14% | ||
3 months | -37.93% | ||
6 months | -53.46% | ||
Current year | -59.33% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.655 | +3.04% | 1,311,590 |
24-05-30 | 8.4 | -1.12% | 1,479,396 |
24-05-29 | 8.495 | -5.98% | 2,116,503 |
24-05-28 | 9.035 | -1.58% | 1,393,505 |
24-05-27 | 9.18 | +3.79% | 915,736 |
Delayed Quote Xetra, May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.33% | 1.61B | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- EVT Stock